ATC Group: V09GA01 Technetium (99mTc) sestamibi

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of V09GA01 in the ATC hierarchy

Level Code Title
1 V Various
2 V09 Diagnostic radiopharmaceuticals
3 V09G Cardiovascular system
4 V09GA Technetium (99mTc) compounds
5 V09GA01 Technetium (99mTc) sestamibi

Active ingredients in V09GA01

Active Ingredient

Technetium 99mTc sestamibi is a coordination complex consisting of the radioisotope technetium-99m bound to six methoxyisobutylisonitrile (MIBI) ligands, hence the name sesta (6) MIBI. Following intravenous injection of the drug, Technetium 99mTc sestamibi is taken up by the myocardium, parathyroid, and/or breast tissue.

Related product monographs

Document Type Information Source  
 CARDIOLITE Powder for solution, lyophilized MPI, US: SPL/PLR FDA, National Drug Code (US)
 MIBI TECHNESCAN Kit for radiopharmaceutical preparation MPI, EU: SmPC Health Products Regulatory Authority (IE)
 STAMICIS Kit for radiopharmaceutical preparation MPI, EU: SmPC European Medicines Agency (EU)

United States medicines

Medicines classified under this ATC code globally

Austria (AT)

Croatia (HR)

Estonia (EE)

Finland (FI)

France (FR)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Japan (JP)

Lithuania (LT)

Malta (MT)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.